These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1811899)

  • 41. Discrimination between antibodies to HIV-1 and HIV-2 in sera from northern Zaire.
    Lackner F; Wewalka G; Heinz FX; Prinz A; Stanek G; Werner A; Kebela-Ilunga
    Zentralbl Bakteriol; 1990 Apr; 272(4):554-64. PubMed ID: 2360974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alternative confirmatory strategies in HIV-1 antibody testing.
    Urassa WK; Bredberg-Rådén U; Mbena E; Pålsson K; Minja E; Lema RA; Pallangyo K; Mhalu FS; Biberfeld G
    J Acquir Immune Defic Syndr (1988); 1992; 5(2):170-6. PubMed ID: 1732510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Particle agglutination test: a new technic for the detection of HIV-1 antibodies].
    Müller F; Gromm M; Müller KH
    Immun Infekt; 1988 Aug; 16(4):148-51. PubMed ID: 3053422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of quality control procedures for the human immunodeficiency virus type 1 antibody enzyme-linked immunosorbent assay.
    Kudlac J; Hanan S; McKee GL
    J Clin Microbiol; 1989 Jun; 27(6):1303-6. PubMed ID: 2754003
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of commercial enzyme immunoassays for anti-HIV-1 using East African sera.
    Bredberg-Rådén U; Kiango J; Mhalu F; Biberfeld G
    AIDS; 1988 Aug; 2(4):281-5. PubMed ID: 3140834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Performance of a rapid immunochromatographic screening test for detection of antibodies to human immunodeficiency virus type 1 (HIV-1) and HIV-2: experience at a tertiary care hospital in South India.
    Vijayakumar TS; David S; Selvaraj K; Viswanathan T; Kannangai R; Sridharan G
    J Clin Microbiol; 2005 Aug; 43(8):4194-6. PubMed ID: 16081975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Development of sera reference panels for quality control of ELISA diagnostic kits in Russia].
    Kanev AN; Vorob'eva MS; Shalunova NV; Karpovich LG; Netesov SV; Maksiutov AZ; Usova SV
    Vestn Ross Akad Med Nauk; 1998; (3):47-51. PubMed ID: 9608278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduction of the cost of testing for antibody to human immunodeficiency virus, without losing sensitivity, by pooling sera.
    Babu PG; Saraswathi NK; Vaidyanathan H; John TJ
    Indian J Med Res; 1993 Jan; 97():1-3. PubMed ID: 8486402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The principles for standardizing serum panels intended for the quality assessment of diagnostic test systems (exemplified by an immunoenzyme test system for detecting HIV antibodies)].
    Kanev AN; Vorob'eva MS; Zagrebel'nyĭ SN; Shirokikh EI; Gorbatov AF; Usova SV; Lomanova GA
    Vopr Virusol; 1992; 37(2):122-4. PubMed ID: 1441431
    [No Abstract]   [Full Text] [Related]  

  • 50. Temperature effect on the sensitivity of ELISA, PA and WB to detect anti-HIV-1 antibody and infectivity of HIV-1.
    Wang GR; Yang JY; Lin TL; Chen HY; Horng CB
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Jun; 59(6):325-33. PubMed ID: 9294911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel approaches to HIV antibody testing.
    Brodie S; Sax P
    AIDS Clin Care; 1997 Jan; 9(1):1-5, 10. PubMed ID: 11363994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of rapid enzyme immunobinding assays for the detection of antibodies to HIV-1.
    Lyons SF
    S Afr Med J; 1993 Feb; 83(2):115-7. PubMed ID: 8451687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The theory and practice of using in-house control in screening and verification studies for the diagnosis of HIV infection].
    Shevelev BI; Ol'shanskiĭ AIa; Redchenko EB; Preobrazhenskaia TV; Klimova NE
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (1):60-1. PubMed ID: 10096206
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of a "dip-stick" methodology for detection of antibodies to HIV1.
    Lyons SF; McGillivray GM; Schoub BD; Smith AN
    Res Virol; 1990; 141(4):465-71. PubMed ID: 2080316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Performance of the Recombigen HIV-1 antibody latex agglutination test.
    Sasse EA; Cardoni D; Dicamelli RF
    Clin Chem; 1989 Oct; 35(10):2140. PubMed ID: 2791286
    [No Abstract]   [Full Text] [Related]  

  • 56. Latex agglutination v. enzyme-linked immunosorbent assays for detection of antibodies to HIV in plasma from Lusaka, Zambia.
    Gould SS; Kabamba JD; Amadi B; Chintu C; Chomba E; Baboo KS; Mathewson JJ; DuPont HL; Murphy JR
    S Afr Med J; 1998 Jan; 88(1):55-6. PubMed ID: 9539942
    [No Abstract]   [Full Text] [Related]  

  • 57. Charting methods for internal quality control for competition ELISA.
    Methods Mol Biol; 2009; 516():335-80. PubMed ID: 19219591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Current diagnosis--screening and diagnosis of HIV infections].
    Tamagawa S
    Nihon Rinsho; 1993 Sep; 51 Suppl():261-8. PubMed ID: 8271391
    [No Abstract]   [Full Text] [Related]  

  • 59. Ruggedness and robustness of tests: aspects of kit use and validation.
    Methods Mol Biol; 2009; 516():431-65. PubMed ID: 19219593
    [No Abstract]   [Full Text] [Related]  

  • 60. From the Centers for Disease Control. Update: serologic testing for HIV-1 antibody--United States, 1988 and 1989.
    JAMA; 1990 Jul; 264(2):171-3. PubMed ID: 2192095
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.